Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus

Background. Regular treatment to prevent bleeding and consequent joint deterioration (prophylaxis) is the standard of care for persons with severe hemophilia A, traditionally based on intravenous infusions of the deficient clotting FVIII concentrates (CFCs). In recent years, extended half-life (EHL)...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Antonio, Franchini, Massimo, Pappagallo, Giovanni, Borchiellini, Alessandra, De Cristofaro, Raimondo, Molinari, Angelo Claudio, Santoro, Rita Carlotta, Santoro, Cristina, Tagliaferri, Annarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837169/
https://www.ncbi.nlm.nih.gov/pubmed/35160253
http://dx.doi.org/10.3390/jcm11030801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837169/
https://www.ncbi.nlm.nih.gov/pubmed/35160253
http://dx.doi.org/10.3390/jcm11030801

Ejemplares similares